Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 367-374

  Fiorina, Paolo ^a,b   Vezzulli, Paolo ^b   Bassi, Roberto ^a,c   Gremizzi, Chiara ^b   Falautano, Monica ^b   D'Addio, Francesca ^b   Vergani, Andrea ^a   Chabtini, Lola ^a   Altamura, Erica ^b   Mello, Alessandra ^b   Caldara, Rossana ^b   Scavini, Marina ^b   Magnani, Giuseppe ^b   Falini, Andrea ^b,d   Secchi, Antonio ^b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF SALENTO   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTELLECT; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; MALE; MENTAL FUNCTION; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTOPERATIVE PERIOD; PROTEIN ANALYSIS;

ADULT; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION;

EID: 84859049370     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1697     Document Type: Article

References (40)

1. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose in tolerance. Diabetes 1979;28:1039-1057
2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
3. Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E. Type 1diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol 2010;223:422-431
4. Sima AA. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010;47:279-293
5. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004;61:661-666 (Pubitemid 38637681)
6. Franceschi M, Cecchetto R, Minicucci F, Smizne S, Baio G, Canal N. Cognitive processes in insulin-dependent diabetes. Diabetes Care 1984;7:228-231
7. Ryan C, Vega A, Longstreet C, Drash A. Neuropsychological changes in adolescents with insulin-dependent diabetes. J Consult Clin Psychol 1984;52:335-342 (Pubitemid 15078640)
8. Pozzessere G, Rizzo PA, Valle E, et al. Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control. Diabetes Care 1988;11:473-480
9. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002;441:1-14 (Pubitemid 34465684)
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
11. O'Brien JT, Paling S, Barber R, et al. Progressive brain atrophy onserial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001;56:1386-1388 (Pubitemid 32455303)
12. Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R. White matter hyperintensities onMRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995;26:1171-1177
13. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility inmeasuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997;244:266-270 (Pubitemid 27156478)
14. Gonen O, Grossman RI. The accuracy of whole brain N-acetylaspartate quantification. Magn Reson Imaging 2000;18:1255-1258 (Pubitemid 32121441)
15. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191-247
16. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52
17. Fiorina P, Perseghin G, De Cobelli F, et al. Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation. Diabetes Care 2007;30:597-603 (Pubitemid 46354340)
18. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75 (Pubitemid 28304880)
19. Albrecht RR, Ewing SJ. Standardizing the administration of the Profile of Mood States (POMS): development of alternative word lists. J Pers Assess 1989;53:31-39
20. De Leo D, Diekstra RF, Lonnqvist J, et al. LEIPAD, aninternationally applicable instrument to assess quality of life in the elderly. Behav Med 1998;24:17-27 (Pubitemid 28204012)
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". Apractical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
22. DeRenzi E. The Token Test: asensitive test to detect receptive disturbance in aphasia. Brain 1962;65:665-678
23. Cohn NB, Dustman RE, Bradford DC. Age-related decrements inStroop Color Test performance. J Clin Psychol 1984;40:1244-1250 (Pubitemid 14002227)
24. Tombaugh TN. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 2006;21:53-76 (Pubitemid 41802927)
25. White RF, Gerr F, Cohen RF, et al. Criteria for progressive modification of neurobehavioral batteries. Neurotoxicol Teratol 1994;16:511-524 (Pubitemid 24305387)
26. Feldstein SN, Keller FR, Portman RE, Durham RL, Klebe KJ, Davis HP. A comparison of computerized and standard versions of the Wisconsin Card Sorting Test. Clin Neuropsychol 1999;13:303-313 (Pubitemid 30040142)
27. Fiorina P, Folli F, D'Angelo A, et al. Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes 2004;53:2291-2300 (Pubitemid 39145582)
28. Larsen JL, Stratta RJ, Ozaki CF, Taylor RJ, Miller SA, Duckworth WC. Lipid status after pancreas-kidney transplantation. Diabetes Care 1992;15:35-42
29. Lai PH, Chen PC, Chang MH, et al. In vivo proton MRspectroscopy of chorea-ballismus in diabetes mellitus. Neuroradiology 2001;43:525-531 (Pubitemid 32677182)
30. Hershey T, Perantie DC, Wu J, Weaver PM, Black KJ, White NH. Hippocampal volumes in youth with type 1 diabetes. Diabetes 2010;59:236-241
31. McCall AL. Diabetes mellitus and the central nervous system. Int Rev Neurobiol 2002;51:415-453
32. Wootton-Gorges SL, Buonocore MH, Caltagirone RA, Kuppermann N, Glaser NS. Progressive decrease in N-acetylaspartate/Creatine ratio in a teenager with type 1 diabetes and repeated episodes of ketoacidosis without clinically apparent cerebral edema: evidence for permanent brain injury. AJNR Am J Neuroradiol 2010;31:780-781
33. Vlassara H, Brownlee M, Cerami A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 1983;32:670-674 (Pubitemid 13062852)
34. Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol 2011;31:139-143
35. Geissler A, Fründ R, Kohler S, Eichhorn HM, Krämer BK, Feuerbach S. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy. Radiology 1995;194:693-697
36. Luan FL, Miles CD, Cibrik DM, Ojo AO. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation 2007;84:541-544 (Pubitemid 47312167)
37. Vicari AM, Taglietti MV, Pellegatta F, et al. Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. A possible link to increased cardiovascular mortality? Diabetes Care 1996;19:1062-1066 (Pubitemid 26334252)
38. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983;308:8-12 (Pubitemid 13211265)
39. Brancaccio D, Bellasi A, Cozzolino M, Galassi A, Gallieni M. Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification. Curr Vasc Pharmacol 2009;7:374-380
40. Wolf FM, Jacober SJ, Wolf LL, Cornell RG, Floyd JC Jr. Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus. J Clin Epidemiol 1989;42:1129-1136 (Pubitemid 20018450)